CD4 count at presentation for HIV care in the United States and Canada: Are those over 50 years more likely to have a delayed presentation?
2010

CD4 Count at Presentation for HIV Care in Older Adults

Sample size: 44491 publication Evidence: high

Author Information

Author(s): Keri N Althoff, Kelly A Gebo, Stephen J Gange, Marina B Klein, John T Brooks, Robert S Hogg, Ronald J Bosch, Michael A Horberg, Michael S Saag, Mari M Kitahata, Joseph J Eron, Sonia Napravnik, Sean B Rourke, John M Gill, Benigno Rodriguez, Timothy R Sterling, Steven G Deeks, Jeffrey N Martin, Lisa P Jacobson, Gregory D Kirk, Ann C Collier, Constance A Benson, Michael J Silverberg, James J Goedert, Rosemary G McKaig, Jennifer Thorne, Anita Rachlis, Richard D Moore, Amy C Justice

Primary Institution: Johns Hopkins Bloomberg School of Public Health

Hypothesis

Are individuals over 50 years more likely to have a delayed presentation for HIV care?

Conclusion

Older individuals presenting for HIV care have lower CD4 counts and a higher proportion of AIDS-defining diagnoses compared to younger individuals.

Supporting Evidence

  • The proportion of individuals presenting for HIV care who were aged ≥50 years increased from 17% to 27% from 1997 to 2007.
  • The median CD4 count among individuals aged ≥50 years was consistently lower than that of younger adults.
  • A greater proportion of older individuals had an AIDS-defining diagnosis at first presentation for HIV care compared to younger individuals.

Takeaway

This study found that older people with HIV are often diagnosed later and have lower immune health when they start treatment.

Methodology

The study analyzed CD4 counts at first presentation for HIV care among individuals aged 50 and older from 1997 to 2007 across 13 clinical cohorts in the US and Canada.

Limitations

The study lacked data on the time since seroconversion and could not stratify older ages further due to sample size limitations.

Participant Demographics

Participants included HIV-infected individuals aged 50 and older from diverse clinical cohorts in the US and Canada.

Statistical Information

P-Value

<0.01

Confidence Interval

[5, 9]

Statistical Significance

p<0.01

Digital Object Identifier (DOI)

10.1186/1742-6405-7-45

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication